Supplemental material
OncoImmunology
Volume 13, 2024 - Issue 1
Open access
448
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Candidate tumor-specific CD8+ T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis
Yusuke Sugitaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan;b Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, JapanView further author information
, Daisuke Muraokaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Ayako Demachi-Okamuraa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Hiroyasu Komuroa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Katsuhiro Masagoc Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
, Eiichi Sasakic Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
, Yasunori Fukushimaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Takuya Matsuia Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Shuichi Shinoharaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Yusuke Takahashia Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Reina Nishidaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Chieko Takashimaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, JapanView further author information
, Teppei Yamaguchid Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
, Yoshitsugu Horiod Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
, Kana Hashimotoe Department of Respiratory Internal Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, JapanView further author information
, Ichidai Tanakaf Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanView further author information
, Hiroshi Hamanag Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, JapanView further author information
, Hiroyuki Kishig Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, JapanView further author information
, Daiki Miurah AI Drug Development Division, NEC Corporation, Tokyo, JapanView further author information
, Yuki Tanakah AI Drug Development Division, NEC Corporation, Tokyo, JapanView further author information
, Kousuke Onoueh AI Drug Development Division, NEC Corporation, Tokyo, JapanView further author information
, Kazuhide Onoguchih AI Drug Development Division, NEC Corporation, Tokyo, JapanView further author information
, Yoshiko Yamashitah AI Drug Development Division, NEC Corporation, Tokyo, JapanView further author information
, Richard Stratfordi NEC OncoImmunity AS, Oslo Cancer Cluster, Oslo, NorwayView further author information
, Trevor Clancyi NEC OncoImmunity AS, Oslo Cancer Cluster, Oslo, NorwayView further author information
, Rui Yamaguchij Division of Cancer System Biology, Aichi Cancer Center Research Institute, Nagoya, Japan;k Division of Cancer Informatics, Nagoya University Graduate School of Medicine, Nagoya, JapanView further author information
, Hiroaki Kurodal Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
, Hironori Ishibashib Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, JapanView further author information
, Kenichi Okubob Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, JapanView further author information
& Hirokazu Matsushitaa Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan;m Division of Cancer Immunogenomics, Nagoya University Graduate School of Medicine, Nagoya, JapanCorrespondence[email protected]
https://orcid.org/0000-0001-9069-7160View further author information
Article: 2371556
|
Received 27 Oct 2023, Accepted 19 Jun 2024, Published online: 28 Jun 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.